Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Interventional × Alginates × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Mucositis 1 Esophagitis 1 Breast Neoplasms 1

Interventions

Cisplatin 1321 Carboplatin 1239 Cyclophosphamide 1177 Gemcitabine 1076 Bevacizumab 1073 Paclitaxel 1055 Radiotherapy 1042 Docetaxel 967 pembrolizumab 900 Oxaliplatin 815 Capecitabine 800 Fluorouracil 751 Rituximab 651 Doxorubicin 588 Nivolumab 587 Dexamethasone 584 Etoposide 582 Irinotecan 558 Leucovorin 517 Pemetrexed 440 Drug Therapy 419 Cetuximab 415 Cytarabine 408 Trastuzumab 404 Magnetic Resonance Spectroscopy 394 Filgrastim 389 Prednisone 374 Lenalidomide 353 Bortezomib 352 Temozolomide 349

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06958445 2025-05-06

SAFE

Taipei City Hospital

Phase 2 Enrolling by invitation

Breast Neoplasms, Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡